Purchase Order HHSF223201211187P

Award Date 8/28/12
Potential Completion Date 9/3/14
Potential Value $118K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Yonkers, NY 10710, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Nanoscale Corporation. The $831,900 contract is for the development of "functionalized bimagnetic core/shell Fe/Fe3O4 stealth nanoparticles" for the diagnosis and treatment of cancer. The contract includes two major subcontractors - Xenometrics, LLC, which will conduct toxicology testing, and the...
This is a $1,000,000.00 Phase II SBIR contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The contract is for the rapid screening of individual cells using single cell mass spectrometry, supporting the NCI's biomedical research and development efforts. Nanocomposix has previously supported other federal agencies such as the Department of Defense...
The Department of the Navy's Naval Air Systems Command awarded a $239,939 Firm Fixed Price Definitive Contract to Nano-C, Inc., a small business manufacturer of nanostructured carbon materials, under the Small Business Technology Transfer (STTR) Research Phase I program. This contract is to develop a proposed topic. Nano-C has previously provided nanostructured carbon additives and conductive inks to Department of Defense and Department of Energy prime contractors through federal contract...
The Department of Health and Human Services Food and Drug Administration awarded a $25,025 firm fixed price purchase order to Nanocomposix, LLC for the production of amino-functionalized silica nanoparticles for in vivo analysis of blood-brain barrier safety and integrity. Performance will take place in Silver Spring, Maryland by September 15, 2023. No set-aside designation was applied to this contract for Nanocomposix to deliver amino-functionalized silica nanoparticles to the FDA, presumably...
This is a $150,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the U.S. Air Force Materiel Command to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The contract is for the development of passive nanoparticle coatings with high visible luminous transmittance and near-infrared blocking capabilities. Nanocomposix has prior experience as both a prime contractor and subcontractor on federal contracts, including work for the Department of...
The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a $249,950.00 firm fixed price purchase order to Nanocomposix, Inc. for the development of a Lateral Assay Device. Nanocomposix is a manufacturer of engineered nanoparticles that has previously supported federal contracts for lateral flow assays, vaccines, and diagnostics. The contract is not set aside for any socioeconomic program. Nanocomposix has produced pilot lots for clinical trials...
Nanocomposix, Inc. was awarded a $300,000 firm fixed price Small Business Innovation Research Phase I contract from the National Institutes of Health's National Institute of Allergy and Infectious Diseases. This contract is in response to a solicitation seeking proposals for research and development of alternatives to cell culture materials, cancer immunotherapy manufacturing methods, and other biomedical technologies. Specifically, Nanocomposix will design and synthesize a new PLGA-based...
This is a $1,500,000.00 Firm Fixed Price contract awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The objective of the contract is to develop cytomegalovirus (CMV) IgG and IgM lateral flow assays required to support a large-scale CMV vaccination trial. Nanocomposix has prior experience providing lateral flow assay devices,...
<p>This is a $750,000.00 Small Business Innovation Research (SBIR) Phase II contract awarded by the Department of the Air Force Materiel Command to Nanocomposix, Inc., a manufacturer of engineered nanoparticles, for the development of passive nanoparticle coatings. Nanocomposix has previously provided products and services to other federal agencies such as the Department of Health and Human Services and the Department of Defense. This contract is set aside for small businesses.</p>
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Small Business Innovation Research (SBIR) Program Phase I contract to Nanocomposix, Inc., a manufacturer of engineered nanoparticles, to build a proof of concept lateral flow rapid diagnostic to identify the serological status of individuals with respect to cytomegalovirus (CMV). The contract, valued at $224,887.00, requires the contractor to characterize...

CLOSELY ASSOCIATED - RESEARCH - NANO PARTICLE INVESTIGATION

Posted 8/28/12, 12:00 AM